FDA approves anti-allergy agent from Alcon

The U.S. Food and Drug Administration has granted U.S. marketing approval to Pazeo, a solution for ocular allergy itch relief from Alcon. Pazeo (olopatadine HCl ophthalmic solution) 0.7% is a once-daily drop designed to relieve itching related to allergic conjunctivitis for 24 hours, according to a press release from Alcon.

Full Story →